Showing results (481-490 of 4,125) with videos related to
Sort By:
Pageof 413
Annals of Neurology|July 1, 1992
Dystonia induced by combined treatment with L-dopa and MK-801 in parkinsonian monkeysN M Rupniak, S Boyce, M J Steventon, et al.Brain : a Journal of Neurology|April 1, 1996
Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UKO C Cockerell, J Rothwell, P D Thompson, et al.Neuropharmacology|June 1, 1984
Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to ratsK Murugaiah, S Fleminger, M D Hall, et al.Clinical Neuropathology|January 1, 1982
Morphologic studies on adult neuronal-ceroid lipofuscinosis (NCL)H H Goebel, H Braak, D Seidel, et al.Clinical Neuropharmacology|February 1, 1989
The antiparkinsonian activity of CQA 206-291, a new D2 dopamine receptor agonistJ A Temlett, N P Quinn, C D Marsden, et al.British Journal of Pharmacology|March 1, 1973
Some initial animal and human pharmacological studies with benapryzine (BRL 1288)D M Brown, B O Hughes, C D Marsden, et al.Neuroscience Letters|March 20, 1987
Different sites of action of electrical and magnetic stimulation of the human brainB L Day, P D Thompson, J P Dick, et al.Brain : a Journal of Neurology|September 1, 1977
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepamD Chadwick, M Hallett, R Harris, et al.Journal of Neurology|January 1, 1996
Double-blind study of the activity and tolerability of cabergoline versus placebo in parkinsonians with motor fluctuationsM J Steiger, T El-Debas, T Anderson, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controlsH S Markus, A J Lees, G Lennox, et al.Pageof 413